- $1.87m
- -$1.27m
- $2.49m
Brief: Geovax Reports 2022 Second Quarter Financial Results And Provides Corporate Update
U.S. STOCKS ON THE MOVE-Freshworks, Loews
U.S. STOCKS ON THE MOVE-ToughBuilt Industries Inc, Koss Corp, Centene Corp
U.S. STOCKS ON THE MOVE-Lakeland Financial, World Wrestling Entertainment, Bank of Marin
U.S. STOCKS ON THE MOVE-Soligenix, Veru, American Express
U.S. STOCKS ON THE MOVE-Tesla Inc, MP Materials Corp, Revelation Bioscience
Smallpox drugmakers surge after monkeypox declared health emergency
Brief: Geovax Labs Files Prospectus Relates To Resale Of Up To 21.4 Million Shares By Selling Stockholders - SEC Filing
Smallpox drugmakers jump as WHO calls for increased Monkeypox surveillance
Brief: Geovax Announces $20 Million Registered Direct And PIPE Offerings
GeoVax jumps on patent for cancer vaccine in China
Brief: GeoVax Receives Notice Of Allowance For Cancer Vaccine Patent In China
U.S. STOCKS ON THE MOVE-JPMorgan, Citigroup, Broadcom, VMware
U.S. STOCKS ON THE MOVE-JPMorgan, Etsy, Ross Stores, VMware
Smallpox drugmakers rally as WHO expects more cases of monkeypox
U.S. STOCKS ON THE MOVE-Parsons Corp, GameStop, Didi, VMware
US STOCKS-Wall St set to rebound after volatile week; takeover talks boost VMware
Smallpox drugmakers rally as WHO expects more cases of monkeypox
GeoVax Labs Inc reports results for the quarter ended in March - Earnings Summary